Skip to main content

Table 4 Levels of microRNA 17-3P, CEA, and CA19.9 among group A and group B patients

From: Role of circulating miRNA-17-3P as a potential diagnostic biomarker for sporadic colon cancer in Egyptian cohort

miRNAGroup A (stage II + III ) (n = 25)Group B (stage IV) (n = 25)UP
Min.–max.1.74–29.862.71–32.451.0< 0.001*
Mean ± SD7.48 ± 6.9210.66 ± 7.37
Median5.288.69
CA19.9
 Min.–max.0.25–63.00.62–700.093.0< 0.001*
 Mean ± SD19.95 ± 17.2558.86 ± 135.5
 Median12.032.0
CEA
 Min.–max.0.70–41.00.10–110.0296.00.749
 Mean ± SD5.48 ± 8.0911.78 ± 28.28
 Median2.902.70